Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12611000844943
Ethics application status
Approved
Date submitted
8/08/2011
Date registered
10/08/2011
Date last updated
13/07/2021
Date data sharing statement initially provided
13/07/2021
Date results provided
13/07/2021
Type of registration
Retrospectively registered

Titles & IDs
Public title
A prospective randomised controlled trial comparing vaginal prolapse repair with and without Tensionfree Vaginal Tape (TVT) in women with severe genital prolapse and occult stress incontinence
Scientific title
A prospective randomised controlled trial comparing vaginal prolapse repair with and without Tensionfree Vaginal Tape (TVT) in women with severe genital prolapse and occult stress incontinence: Long term follow up
Secondary ID [1] 262776 0
Nil
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Treatment of occult stress urinary incontinence in conjunction with prolapse repair 270483 0
Condition category
Condition code
Surgery 270640 270640 0 0
Surgical techniques
Renal and Urogenital 270676 270676 0 0
Other renal and urogenital disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Insertion of TVT suburethral sling at time of prolapse repair. The TVT procedure (Gynecare, Ethicon Inc., Somerville, NJ) was performed as previously described by Ulmsten. The tape is passed from the vagina retropubically without tension. The tape is a permanent synthetic mesh. The procedure takes 10-15 min including cystoscopy to excluded any bladder perforation.
Intervention code [1] 267117 0
Treatment: Surgery
Intervention code [2] 269156 0
Treatment: Devices
Comparator / control treatment
The prolapse repair is performed according to surgeon preference and the participants need. The prolapse repair alone without suburethral sling insertion is the control arm.
Control group
Active

Outcomes
Primary outcome [1] 269368 0
Need for stress incontinence surgery after prolapse repair determined by symptomatic stress urinary incontinence as well as urodynamics stress incontinence demonstrated by the urodynamics test at 6 month follow up
Timepoint [1] 269368 0
any time after primary surgery for up to 10 years
Primary outcome [2] 269396 0
urodynamic stress incontinence at 6 month post surgery
Timepoint [2] 269396 0
6 months
Secondary outcome [1] 279459 0
subjective cure rate such as patient reports no symptoms of stress incontinence, report a numerical success score of greater than or equal to 80 out of 100, quality of life questionnaires (UDI 6 and IIQ7)
Timepoint [1] 279459 0
six month and 12 months post surgery, than yearly follow up to 5 years
Secondary outcome [2] 287547 0
intra- and post-operative complications such as haemorrhage requiring blood transfusion, visceral damage, voiding difficulty, pain (immediate at the time of surgery, short term complications in the first 6 weeks, postoperatively and long-term)
Timepoint [2] 287547 0
immediate, first 6 weeks, six month and 12 months post surgery, than yearly follow up to 5 years
Secondary outcome [3] 287549 0
urgency and urge incontinence, assessed by history and bladder diary.
Timepoint [3] 287549 0
six month and 12 months post surgery, than yearly follow up to 5 years

Eligibility
Key inclusion criteria
pelvic organ prolapse = / > Grade 2, requiring surgical correction in absence of SUI and with urodynamically demonstrated OSI. Ability to give informed consent and willingness to participate are required
Minimum age
18 Years
Maximum age
No limit
Sex
Females
Can healthy volunteers participate?
No
Key exclusion criteria
Contraindication to surgery in general such as being medically unfit for surgery, the presence of pelvic infection, malignancy, fistula, congenital or neurogenic bladder disorder, and inability to give informed consent.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
central randomisation by phone /fax /computer
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation by using a randomization table created by a computer software (i.e. computerised sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Randomization to either recieve the TVT suburethral sling at the time of prolapse repair or have prolapse repair alone.
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
2/05/2003
Actual
2/05/2003
Date of last participant enrolment
Anticipated
Actual
28/08/2009
Date of last data collection
Anticipated
Actual
22/02/2013
Sample size
Target
80
Accrual to date
Final
80
Recruitment in Australia
Recruitment state(s)
VIC

Funding & Sponsors
Funding source category [1] 269598 0
Self funded/Unfunded
Name [1] 269598 0
Country [1] 269598 0
Primary sponsor type
Hospital
Name
Mercy Hospital for Women
Address
163 Studley Road
Heidelberg
Vic 3084
Country
Australia
Secondary sponsor category [1] 266632 0
Hospital
Name [1] 266632 0
Monash Medical Centre
Address [1] 266632 0
246 Clayton Road
Clayton
Vic 3168
Country [1] 266632 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 269551 0
HREC Mercy Hospital for Women
Ethics committee address [1] 269551 0
Ethics committee country [1] 269551 0
Australia
Date submitted for ethics approval [1] 269551 0
Approval date [1] 269551 0
02/05/2003
Ethics approval number [1] 269551 0
R03/06

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 32974 0
Dr Lore Schierlitz
Address 32974 0
Mercy Hospital for Women
163 Studley Rd
Heidelberg Vic 3084
Country 32974 0
Australia
Phone 32974 0
+61 3 84584890
Fax 32974 0
Email 32974 0
lschierlitz@mercy.com.au
Contact person for public queries
Name 16221 0
Dr. Lore Schierlitz
Address 16221 0
Mercy Hospital for Women
163 Studley Rd
Heidelberg
Vic 3084
Country 16221 0
Australia
Phone 16221 0
61 3 84584890
Fax 16221 0
Email 16221 0
lschierlitz@mercy.com.au
Contact person for scientific queries
Name 7149 0
Dr. Lore Schierlitz
Address 7149 0
Mercy Hospital for Women
163 Studley Rd
Heidelberg
Vic 3084
Country 7149 0
Australia
Phone 7149 0
61 3 84584890
Fax 7149 0
Email 7149 0
lschierlitz@mercy.com.au

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.